Canopy Growth Corporation (CGC)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$0.92
-0.75%
Mkt Cap $392.60M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$14.47
Range $8.00 – $27.85
Implied Upside
+1467.7%
Consensus $14.47 vs current $0.92